Association of cardiac autonomic neuropathy with arterial stiffness in type 2 diabetes mellitus patients

BackgroundDiabetic patients are at the risk of cardiac autonomic neuropathy (CAN) and arterial stiffness. This study aimed to investigate the association of heart rate variability (HRV) as an index for CAN and pulse wave velocity (PWV) as an index for arterial stiffness.MethodsUncomplicated diabetes type-2 patients who had no apparent history of cardiovascular condition underwent HRV and PWV measurements and the results were compared with the control group consisting of non-diabetic peers. Also, the findings were adjusted for the cardiovascular risk factors and other confounding factors.ResultsA total of 64 diabetic patients (age= 52.08±8.50 years; males=33 [51.6%]) were compared with 57 controls (age= 48.74±6.18 years; males=25 [43.9%]) in this study. Hypertension, dyslipidemia, and thereby systolic blood pressure and statin use were significantly more frequent in the diabetic group, while the serum levels of cholesterol, HDL-C and LDL-C were significantly higher in the controls. Pulse wave was significantly increased in the diabetic patients (p<0.001). Main HRV parameters were significantly lower in diabetics than in controls. After adjustment for the confounders, PWV and HRV remained significantly different between the groups (p=0.01 and p=0.004, respectively). Multiple logistic regression of the association between pulse wave velocity and HRV index was independently significant both in diabetics and controls.ConclusionsThere exists a significant relationship between heart rate variability and arterial stiffness as a measure for atherosclerosis in diabetic patients, although the role of the confounding factors is noteworthy.

[1]  M. Mirarefin,et al.  Cardiac Autonomic Neuropathy Measured by Heart Rate Variability and Markers of Subclinical Atherosclerosis in Early Type 2 Diabetes , 2012, ISRN endocrinology.

[2]  A. Kotsia,et al.  Increased aortic pulse wave velocity is associated with the presence of angiographic coronary artery disease in overweight and obese patients. , 2013, American journal of hypertension.

[3]  A. Malliani,et al.  Cardiovascular Neural Regulation Explored in the Frequency Domain , 1991, Circulation.

[4]  Tine Willum Hansen,et al.  Prognostic Value of Aortic Pulse Wave Velocity as Index of Arterial Stiffness in the General Population , 2006, Circulation.

[5]  H. Huikuri,et al.  Heart rate variability in ischemic heart disease , 2001, Autonomic Neuroscience.

[6]  G. Breithardt,et al.  Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. , 1996 .

[7]  R Maestri,et al.  Physiology and pathophysiology of heart rate and blood pressure variability in humans: is power spectral analysis largely an index of baroreflex gain? , 1995, Clinical science.

[8]  Elena Ratto,et al.  Increased Ambulatory Arterial Stiffness Index Is Associated With Target Organ Damage in Primary Hypertension , 2006, Hypertension.

[9]  T. Orchard,et al.  Pulse wave analysis and cardiac autonomic neuropathy in type 1 diabetes: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. , 2011, Diabetes technology & therapeutics.

[10]  J. Shaw,et al.  Global estimates of the prevalence of diabetes for 2010 and 2030. , 2010, Diabetes research and clinical practice.

[11]  J. Staessen,et al.  Independent prognostic value of the ambulatory arterial stiffness index and aortic pulse wave velocity in a general population , 2008, Journal of Human Hypertension.

[12]  P. Ducimetiere,et al.  Aortic Stiffness Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Hypertensive Patients , 2001, Hypertension.

[13]  M. Vaz,et al.  Autonomic nervous system function in type 2 diabetes using conventional clinical autonomic tests, heart rate and blood pressure variability measures , 2011, Indian journal of endocrinology and metabolism.

[14]  E. Rodríguez-Sánchez,et al.  Ambulatory arterial stiffness indices and target organ damage in hypertension , 2012, BMC Cardiovascular Disorders.

[15]  Vincent C. Arena,et al.  Cardiovascular Autonomic Neuropathy, HDL Cholesterol, and Smoking Correlate With Arterial Stiffness Markers Determined 18 Years Later in Type 1 Diabetes , 2009, Diabetes Care.

[16]  Kazuomi Kario,et al.  Reproducibility of arterial stiffness indices (pulse wave velocity and augmentation index) simultaneously assessed by automated pulse wave analysis and their associated risk factors in essential hypertensive patients. , 2004, Hypertension research : official journal of the Japanese Society of Hypertension.

[17]  H. Teede,et al.  Vascular dysfunction and autonomic neuropathy in Type 2 diabetes , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[18]  S. Anderson,et al.  Aortic Pulse-Wave Velocity and Its Relationship to Mortality in Diabetes and Glucose Intolerance: An Integrated Index of Vascular Function? , 2002, Circulation.

[19]  A. Malliani,et al.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use , 1996 .

[20]  S. Liatis,et al.  Cardiac Autonomic Function Correlates with Arterial Stiffness in the Early Stage of Type 1 Diabetes , 2011, Experimental diabetes research.

[21]  Braxton D Mitchell,et al.  The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. , 2003, Diabetes care.

[22]  C. Long,et al.  Pulse wave velocity and carotid atherosclerosis in White and Latino patients with hypertension , 2011, BMC cardiovascular disorders.

[23]  H. Svensson,et al.  Sympathetic and parasympathetic neuropathy are frequent in both type 1 and type 2 diabetic patients. , 2004, Diabetes care.

[24]  A J Camm,et al.  Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials , 2001, Circulation.